麝香通心滴丸联合西药治疗稳定型心绞痛临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.4

基金项目:


Clinical Study on Shexiang Tongxin Dropping Pills Combined with Western Medicine for Stable Angina Pectoris
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察麝香通心滴丸联合西药治疗稳定型心绞痛(SAP) 的临床疗效。方法:选取98 例SAP 患者,按不同治疗方法分为对照组和观察组,每组49 例。对照组给予西药治疗,观察组采用麝香通心滴丸联合西药治疗,2 组均连续治疗4 周。比较2 组治疗前后中医症状评分,心绞痛发作次数,心绞痛持续时间,白细胞介素-6(IL-6)、超敏C-反应蛋白(hs-CRP)、血脂指标水平及6 min 步行试验(6MWT) 距离;比较2 组临床疗效。结果:治疗后,2 组胸痛、气短、心悸评分均较治疗前降低(P<0.05),观察组胸痛、气短、心悸评分均低于对照组(P<0.05)。治疗后,2 组心绞痛发作次数均较治疗前减少(P<0.05),心绞痛持续时间均较治疗前缩短(P<0.05);观察组心绞痛发作次数少于对照组(P<0.05),心绞痛持续时间短于对照组(P<0.05)。治疗后,2 组IL-6、hs-CRP、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C) 水平均较治疗前降低(P<0.05),观察组IL-6、hs-CRP、TC、TG、LDL-C 水平均低于对照组(P<0.05);2 组高密度脂蛋白胆固醇(HDL-C) 水平均较治疗前升高(P<0.05),观察组HDL-C 水平高于对照组(P<0.05);2 组6MWT 距离均较治疗前增大(P<0.05),观察组6MWT 距离大于对照组(P<0.05)。观察组总有效率为93.88%,高于对照组的79.59%(P<0.05)。结论:麝香通心滴丸联合西药治疗SAP 可提高临床疗效,有效缓解心绞痛症状,降低炎症因子及血脂水平,增加步行距离。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Shexiang Tongxin dropping pills combined with western medicine for stable angina pectoris(SAP). Methods: A total of 98 cases of SAP patients were divided into the control group and the observation group according to different treatment methods,with 49 cases in each group. The control group was treated with western medicine, and the observation group was treated with Shexiang Tongxin dropping pills combined with western medicine. Both groups were treated for four weeks. Chinese medicine syndrome scores, onset frequency and duration of angina pectoris, levels of interleukin- 6(IL- 6), tumor necrosis factor- α(TNF- α), high- sensitivity C- reactive protein(hs- CRP) and blood lipid,and distances in Six-Minute Walk Test(6MWT) before and after treatment as well as the clinical effects in the two groups were compared. Results:After treatment,the scores of chest pain,shortness of breath and palpitation in the two groups were decreased when compared with those before treatment(P<0.05), and the scores of chest pain, shortness of breath and palpitation in the observation group were lower than those in the control group(P<0.05). After treatment, the onset frequency of angina pectoris in the two groups was decreased when compared with that before treatment(P<0.05),and the duration of angina pectoris was shortened(P<0.05);the onset frequency of angina pectoris in the observation group was less than that in the control group(P<0.05),and the duration of angina pectoris was shorter(P< 0.05). After treatment, the levels of IL- 6, hs- CRP, total cholesterol(TC), triglyceride(TG) and low- density lipoprotein cholesterol(LDL-C) in the two groups were decreased when compared with those before treatment(P<0.05),and the levels of IL-6,hs-CRP,TC,TG and LDL-C in the observation group were lower than those in the control group(P<0.05);the levels of high- density lipoprotein cholesterol(HDL- C) in the two groups were increased when compared with those before treatment(P<0.05),and the HDL-C level in the observation group was higher than that in the control group(P<0.05);the 6 MWT distances in the two groups were increased when compared with those before treatment(P<0.05),and the distance in the observation group was larger than that in the control group(P<0.05). The total effective rate was 93.88% in the observation group, higher than that of 79.59% in the control group(P<0.05). Conclusion: Shexiang Tongxin dropping pills combined with western medicine for SAP can improve clinical effect,effectively relieve symptom of angina pectoris,reduce levels of inflammatory factors and blood lipid,and increase walking distance.

    参考文献
    相似文献
    引证文献
引用本文

王翔.麝香通心滴丸联合西药治疗稳定型心绞痛临床研究[J].新中医,2021,53(24):65-69

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-12-27
  • 出版日期: